2018 consensus statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology on the diagnosis and treatment of cancer of unknown primary

Losa, F; Iglesias, L; Pané, M; Sanz, J; Nieto, B; Fusté, V; Cruz-Merino, L de la; Concha, Á; Balañá, C; Matías-Guiu, X.
Clin. transl. oncol. (Print) ; 20(11): 1361-1372, nov. 2018. ilus, tab, graf
Artículo en Inglés | IBECS (España) | ID: ibc-173726

Documentos relacionados

  1. From Biology to Diagnosis and Treatment: The Ariadne's Thread in Cancer of Unknown Primary.
  2. Clinical features of cancer with unknown primary site (clinical features, treatment, prognosis of cancer with unknown primary site).
  3. Six-year experience of Australia's first dedicated cancer of unknown primary clinic.
  4. New techniques to identify the tissue of origin for cancer of unknown primary in the era of precision medicine: progress and challenges.
  5. [DIAGNOSTICS AND TREATMENT OF MALIGNANT TUMOURS WITHOUT DETECTED PRIMARY SITE].
  6. Diagnosis and management of metastatic neoplasms with unknown primary.
  7. Carcinoma of unknown primary (CUP): an update for histopathologists.
  8. SEOM-GECOD clinical guideline for unknown primary cancer (2021).
  9. A comparison of DNA sequencing and gene expression profiling to assist tissue of origin diagnosis in cancer of unknown primary.
  10. Frequency and Prognostic Value of Circulating Tumor Cells in Cancer of Unknown Primary.